Trials / Completed
CompletedNCT04223297
Blue Protocol Assessment
Interest Assessment of the Blue Protocol in Improving Diagnosis of Dyspneic Patients in Pre- and Intra-hospital Emergency Medicine
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 115 (actual)
- Sponsor
- Centre Hospitalier Universitaire, Amiens · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Acute dyspnea is a common disease in emergency medicine. Mortality remains high is estimated at 15%. One third of initial diagnoses before paraclinical examination are estimated to be inaccurate. Lung ultrasound is a quick and immediate examination. Also, it is provided and performed at the bedside. The " Blue protocol " was designed by Daniel A. Lichtenstein as a diagnostic aid in dyspneic patients. It allows to obtain a diagnostic in more than 90% of acute dyspnea. However there is no validation in emergency medicine. The main purpose is to evaluate the interest of the " Blue protocol "in the management and orientation of the dyspneic patient
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | lung ultrasound | The lung ultrasound will be performed by following the " Blue protocol " |
Timeline
- Start date
- 2020-01-01
- Primary completion
- 2020-09-01
- Completion
- 2020-09-01
- First posted
- 2020-01-10
- Last updated
- 2023-01-18
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04223297. Inclusion in this directory is not an endorsement.